CNTX-6970 is a novel, potent and selective investigational small molecule CCR2 antagonist administered orally for the treatment of inflammatory chronic pain.
CNTX-6970 is a novel, potent and selective investigational small molecule CCR2 antagonist administered orally for the treatment of inflammatory chronic pain.